AKT1 and neoplasm: Notably, directly opposing the concept of FoxO1 being a tumor suppressor, ~ 46% of FoxO1 mutations involve sites close to T24, a phosphorylation site for negative regulation, making this site unrecognizable for Akt, and subsequently reducing FoxO1 nuclear export.